77 related articles for article (PubMed ID: 7894109)
1. No HLA association with the early development of a single basal cell carcinoma.
Czarnecki D; Nicholson I; Tait B; Meehan C
Dermatology; 1995; 190(1):88. PubMed ID: 7894109
[No Abstract] [Full Text] [Related]
2. HLA and multiple skin carcinomas.
Cerimele D; Contu L; Carcassi C; Costa G; La Nasa G; Sanna E; Campus GV
Dermatologica; 1988; 176(4):176-81. PubMed ID: 3378654
[TBL] [Abstract][Full Text] [Related]
3. Multiple basal cell carcinomas and HLA frequencies in southern Australia.
Czarnecki D; Lewis A; Nicholson I; Tait B
J Am Acad Dermatol; 1991 Apr; 24(4):559-61. PubMed ID: 2033130
[TBL] [Abstract][Full Text] [Related]
4. Relation between skin cancer and HLA antigens in renal-transplant recipients.
Bouwes Bavinck JN; Vermeer BJ; van der Woude FJ; Vandenbroucke JP; Schreuder GM; Thorogood J; Persijn GG; Claas FH
N Engl J Med; 1991 Sep; 325(12):843-8. PubMed ID: 1875968
[TBL] [Abstract][Full Text] [Related]
5. [Expression of HLA-class I and II antigens on basal cell carcinoma].
Nakamura T; Kageshita T; Hirai S; Kimura T; Yoshii A; Ono T; Arao T
Nihon Hifuka Gakkai Zasshi; 1990 Dec; 100(14):1431-5. PubMed ID: 2082044
[TBL] [Abstract][Full Text] [Related]
6. HLA DR4 is associated with the development of multiple basal cell carcinomas and malignant melanoma.
Czarnecki D; Nicholson I; Tait B; Nash C
Dermatology; 1993; 187(1):16-8. PubMed ID: 8324271
[TBL] [Abstract][Full Text] [Related]
7. Skin cancers and HLA frequencies in renal transplant recipients.
Czarnecki D; Watkins F; Leahy S; Dyall-Smith D; Levis A; Nicholson I; Tait B
Dermatology; 1992; 185(1):9-11. PubMed ID: 1638083
[TBL] [Abstract][Full Text] [Related]
8. Multiple basal cell carcinomas: no association with HLA-DRB, HLA-DQA1 or HLA-DQB1 in Swedish patients.
Emtestam L; Wallberg P; Aldener A; Olerup O
Br J Dermatol; 1996 May; 134(5):886-91. PubMed ID: 8736330
[TBL] [Abstract][Full Text] [Related]
9. Interferon-gamma-induced ICAM-1 and CD40 expression, complete lack of HLA-DR and CD80 (B7.1), and inconsistent HLA-ABC expression in basal cell carcinoma: a possible role for interleukin-10?
Kooy AJ; Prens EP; Van Heukelum A; Vuzevski VD; Van Joost T; Tank B
J Pathol; 1999 Feb; 187(3):351-7. PubMed ID: 10398091
[TBL] [Abstract][Full Text] [Related]
10. Multiple basal cell carcinoma in tropical Australia.
Czarnecki D; Collins N; Chow P; Nicholson I; Tait B
Int J Dermatol; 1992 Sep; 31(9):635-6. PubMed ID: 1459761
[TBL] [Abstract][Full Text] [Related]
11. Multiple nonmelanoma skin cancer associated with HLA DR7 in southern Australia.
Czarnecki DB; Lewis A; Nicholson I; Tait B
Cancer; 1991 Jul; 68(2):439-40. PubMed ID: 2070340
[No Abstract] [Full Text] [Related]
12. [Modern programs of treatment and rehabilitation of patients with basaliomas: their pathogenic substantiation and clinical effectiveness].
Snarskaia ES; Suchkov SV; Molochkov VA
Vestn Ross Akad Med Nauk; 2005; (6):41-5. PubMed ID: 16022112
[TBL] [Abstract][Full Text] [Related]
13. HLA phenotypes and multiple basal cell carcinomas.
Rompel R; Petres J; Kaupert K; Mueller-Eckhardt G
Dermatology; 1994; 189(3):222-4. PubMed ID: 7949471
[TBL] [Abstract][Full Text] [Related]
14. Langerhans cells, immunomodulation and skin lesions. A quantitative, morphological and clinical study.
Bergfelt L
Acta Derm Venereol Suppl (Stockh); 1993; 180():1-37. PubMed ID: 7901956
[TBL] [Abstract][Full Text] [Related]
15. Skin cancer and HLA antigens.
Myskowski PL
N Engl J Med; 1992 Mar; 326(11):765; author reply 766. PubMed ID: 1738388
[No Abstract] [Full Text] [Related]
16. Beta-2-microglobulin and HLA-DR(Ia)-antigens in normal and pathological skin.
Tjernlund U
Acta Derm Venereol Suppl (Stockh); 1981; 94():1-40. PubMed ID: 6169248
[No Abstract] [Full Text] [Related]
17. Liposome-mediated gene transfer into human basal cell carcinoma.
Hottiger MO; Dam TN; Nickoloff BJ; Johnson TM; Nabel GJ
Gene Ther; 1999 Dec; 6(12):1929-35. PubMed ID: 10637444
[TBL] [Abstract][Full Text] [Related]
18. [Expression of HLA-Dr and CD1+ cells in malignant and benign pigmentary tumors].
Ramírez-Bosca A; Valcuende-Cavero F; Rufat-Pérez MJ; Castells-Rodellas A
Med Cutan Ibero Lat Am; 1989; 17(1):58-64. PubMed ID: 2474114
[TBL] [Abstract][Full Text] [Related]
19. [Immunoglobulin factor reacting with components of epidermal basement membranes of patients with basal cell carcinoma].
Kogan MG; Bukhova VP; Beletskaia LV; Berenbeĭn BA; Balashova MB
Vestn Dermatol Venerol; 1984 Aug; (8):20-2. PubMed ID: 6485533
[No Abstract] [Full Text] [Related]
20. Dermal infiltrates in basal cell carcinoma.
Manara GC; Ferrari C; Torresani C; De Panfilis G
J Am Acad Dermatol; 1989 Apr; 20(4):701. PubMed ID: 2785540
[No Abstract] [Full Text] [Related]
[Next] [New Search]
